| Code | 70465 | ||||||||||
| MA number | 19/0174/96-S | ||||||||||
| Product Form: | sol inj 15x4 ml/400 mg (amp.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Baxter Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 19 - ANTIDOTA, DETOXICANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | glass ampoule | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 08.02.1996 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Uromitexan 400mg_sol inj_01_2022.pdf
|
| SPC: |
SPC_Uromitexan 400 mg_sol inj_01_2022.pdf
|
| Safety feature | Yes |
| Data update: | 21.05.2018 |
